Dr Michael Ng
Honorary Clinical Associate Professor
Department of Medicine
35 Scholarly works
0 Projects
HIGHLIGHTS
2026
Journal article
Artificial Intelligence impact on decision-making regarding short-term ADT with prostate radiotherapy: ASTuTE clinical trial interim results
DOI: 10.1016/j.ctro.2026.1012572026
Journal article
Adoption of Hypofractionated Radiation Therapy and Quality of Life Outcomes for Localised Prostate Cancer in an Australian Population-Based Cohort
DOI: 10.1111/1754-9485.701832026
Journal article
Stereotactic ablative body radiotherapy for PSMA-PET/CT staged, oligometastatic prostate cancer – A multi-centre study
DOI: 10.1016/j.radonc.2025.1112192025
Journal article
A multicentre implementation trial of an Artificial Intelligence-driven biomarker to inform Shared decisions for androgen deprivation therapy in men undergoing prostate radiotherapy: the ASTuTE protocol
DOI: 10.1186/s12885-025-13622-12025
Journal article
A population-based analyses of the evolving management of cN1M0 prostate cancer in the PSMA-PET era
DOI: 10.1002/bco2.700592024
Journal article
Fluorine-18-labelled Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography or Magnetic Resonance Imaging to Diagnose and Localise Prostate Cancer. A Prospective Single-arm Paired Comparison (PEDAL)
DOI: 10.1016/j.euo.2024.01.0022024
Journal article
Marginal zone lymphomas: a consensus practice statement from the Australasian Lymphoma Alliance
DOI: 10.1111/imj.16390
RECENT SCHOLARLY WORKS
2024
Journal article
Low-dose-rate brachytherapy and long-term treatment outcomes in patients younger than 60 years of age
DOI: 10.5114/jcb.2024.1356302023
Journal article
Re-defining 18F-DCFPyl prostate-specific membrane antigen positron emission tomography detected local recurrence from radical prostatectomy histopathology
DOI: 10.1111/bju.160852023
Journal article
PSMA-PET Detection of Unusual Metastases in Castrate-Sensitive Prostate Carcinoma
DOI: 10.1097/RLU.0000000000004469